European Journal of Pharmacology 2008-01-01

Electrophysiology-based analysis of human histamine H4receptor pharmacology using GIRK channel coupling inXenopusoocytes

Kristoffer Sahlholm, Johanna Nilsson, Daniel Marcellino, Kjell Fuxe, Peter Århem, Kristoffer Sahlholm, Johanna Nilsson, Daniel Marcellino, Kjell Fuxe, Peter Århem

Index: Eur. J. Pharmacol. 591(1-3) , 52-8, (2008)

Full Text: HTML

Abstract

The recently cloned histamine H 4 receptor is expressed predominantly in haematopoietic cells and has been found to modulate the function of mast cells, eosinophils, dendritic cells and T lymphocytes. It represents an attractive target for pharmacological interventions against a number of inflammatory and autoimmune disorders. In the present work we used two-electrode voltage-clamp to demonstrate histamine H 4 receptor modulation of G protein-coupled inward rectifier potassium (GIRK) channels heterologously expressed in Xenopus oocytes. In accordance with earlier findings in other effector systems, full agonism by histamine and ( R)-α-methylhistamine, partial agonism by clobenpropit and inverse agonism by thioperamide were observed. Furthermore, in oocytes injected with low amounts of receptor cRNA, clobenpropit apparently acted as a neutral antagonist. We also used the high temporal resolution afforded by this system to study the differential time courses of response deactivation upon ligand washout for clobenpropit and ( R)-α-methylhistamine. GIRK channels represent a novel effector system for histamine H 4 receptor modulation, which may be of physiological relevance and prove useful in the development of compounds targeting this receptor.


Related Compounds

Related Articles:

Histamine H3 receptor activation counteracts adenosine A2A receptor-mediated enhancement of depolarization-evoked [3H]-GABA release from rat globus pallidus synaptosomes.

2014-08-20

[ACS Chem. Neurosci. 5(8) , 637-45, (2014)]

Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.

2011-12-08

[J. Med. Chem. 54 , 8136-47, (2011)]

Adipogenic and lipolytic effects of chronic glucocorticoid exposure.

2011-01-01

[Am. J. Physiol. Cell Physiol. 300 , C198-209, (2011)]

The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis.

2011-11-01

[Hepatology 54(5) , 1718-28, (2011)]

Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression.

2011-01-01

[BMC Cancer 11 , 195:1-11, (2011)]

More Articles...